Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association
|
May 18, 2021
Otitis Media and Hearing Loss in Patients With Nonsyndromic Craniosynostosis: A Multicenter Study
Jeewanjot S Grewal, Jason E Cohn, Jacob Burdett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1989
The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer
S L Graziano, R Mazid, N Newman, et al.
American Journal of Surgery
|
March 23, 2017
Operative management of chronic pancreatitis: A review
John D Tillou, Jacob A Tatum, Joshua S Jolissaint, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 19, 1998
Analysis of neuroendocrine markers, HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small cell lung cancer: a Cancer and Leukemia Group B study
S L Graziano, J A Kern, J E Herndon, et al.
Clinical Transplantation
|
September 14, 2016
The impact of bacterial colonization on graft success after total pancreatectomy with autologous islet transplantation: considerations for early definitive surgical intervention
Joshua S Jolissaint, Linda W Langman, Claire L DeBolt, et al.
Journal of Virological Methods
|
December 25, 2010
Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid
Stephen R Lee, Keith W Kardos, Eugene Schiff, et al.
The Lancet. Infectious Diseases
|
June 21, 2012
Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial
Stanislas Pol, Reem H Ghalib, Vinod K Rustgi, et al.
Gastroenterology
|
October 15, 2014
Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection
Gregory J Dore, Eric Lawitz, Christophe Hézode, et al.
Gut
|
August 1, 2014
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study
Christophe Hézode, Gideon M Hirschfield, Wayne Ghesquiere, et al.
Toxicon: X
|
July 19, 2021
Citizen science and online data: Opportunities and challenges for snake ecology and action against snakebite
Andrew M Durso, Rafael Ruiz de Castañeda, Camille Montalcini, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
The Cleft Palate-Craniofacial Journal : Official Publication of the American Cleft Palate-Craniofacial Association
|
May 18, 2021
Otitis Media and Hearing Loss in Patients With Nonsyndromic Craniosynostosis: A Multicenter Study
Jeewanjot S Grewal, Jason E Cohn, Jacob Burdett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1989
The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer
S L Graziano, R Mazid, N Newman, et al.
American Journal of Surgery
|
March 23, 2017
Operative management of chronic pancreatitis: A review
John D Tillou, Jacob A Tatum, Joshua S Jolissaint, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 19, 1998
Analysis of neuroendocrine markers, HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small cell lung cancer: a Cancer and Leukemia Group B study
S L Graziano, J A Kern, J E Herndon, et al.
Clinical Transplantation
|
September 14, 2016
The impact of bacterial colonization on graft success after total pancreatectomy with autologous islet transplantation: considerations for early definitive surgical intervention
Joshua S Jolissaint, Linda W Langman, Claire L DeBolt, et al.
Journal of Virological Methods
|
December 25, 2010
Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid
Stephen R Lee, Keith W Kardos, Eugene Schiff, et al.
The Lancet. Infectious Diseases
|
June 21, 2012
Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial
Stanislas Pol, Reem H Ghalib, Vinod K Rustgi, et al.
Gastroenterology
|
October 15, 2014
Daclatasvir plus peginterferon and ribavirin is noninferior to peginterferon and ribavirin alone, and reduces the duration of treatment for HCV genotype 2 or 3 infection
Gregory J Dore, Eric Lawitz, Christophe Hézode, et al.
Gut
|
August 1, 2014
Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study
Christophe Hézode, Gideon M Hirschfield, Wayne Ghesquiere, et al.
Toxicon: X
|
July 19, 2021
Citizen science and online data: Opportunities and challenges for snake ecology and action against snakebite
Andrew M Durso, Rafael Ruiz de Castañeda, Camille Montalcini, et al.
Page
of 8